SCHEMBL1954071

SCHEMBL1954071

CCC(C(=O)O)(c1ccc(C)cc1C)c1ccc(C)cc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 2/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ TDP1 Q9NUW8 2/20 0.38
▸ TSHR P16473 2/20 0.38
▸ TTR P02766 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2C8 P10632 1/20 0.38
▸ CHRM1 P11229 1/20 0.38
▸ ADRA1A P35348 1/20 0.38
▸ PPARG P37231 1/20 0.38
▸ HTR2B P41595 1/20 0.38
▸ PPARA Q07869 1/20 0.38
▸ SLCO1B3 Q9NPD5 1/20 0.38
▸ CISD1 Q9NZ45 1/20 0.38
▸ SLCO1B1 Q9Y6L6 1/20 0.38
▸ GUCY1A1 Q02108 1/20 0.37
▸ GUCY1B1 Q02153 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16672509 0.76 CYP2C9 (0.36) CYP2C9SMN1; SMN2MEN1KMT2ATDP1
SCHEMBL8974281 0.76 CYP2C9 (0.33) CYP2C9SMN1; SMN2MEN1KMT2ATDP1
SCHEMBL16673010 0.76 CYP2C9 (0.36) CYP2C9SMN1; SMN2MEN1KMT2ATDP1
SCHEMBL6839570 0.76 MEN1 (0.43) CYP2C9SMN1; SMN2MEN1KMT2ATDP1
SCHEMBL11668071 0.76 CYP2C9 (0.40) CYP2C9SMN1; SMN2MEN1KMT2ATDP1
SCHEMBL6838457 0.74 CYP2C9 (0.39) CYP2C9SMN1; SMN2MEN1KMT2ATDP1
SCHEMBL12525117 0.73 TP53 (0.41) SMN1; SMN2MEN1KMT2ATDP1ALDH1A1
SCHEMBL9220402 0.72 CASR (0.41) CYP2C9SMN1; SMN2MEN1KMT2ATDP1
SCHEMBL6806145 0.71 MAPT (0.38) CYP2C9SMN1; SMN2MEN1KMT2ATDP1
SCHEMBL15678397 0.71 MEN1 (0.41) CYP2C9SMN1; SMN2MEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12551590-B2 Apparatus and method to measure concentration of disinfectant in medical device reprocessing system ASP GLOBAL MANUFACTURING GMBH (CH) 2026-02-17 — — US claimed
EP-4257074-A2 REAGENT SOLUTION TO MEASURE CONCENTRATION OF DISINFECTANT ASP Global Manufacturing GmbH (CH) 2023-10-11 — — EP claimed
US-20220401603-A1 APPARATUS AND METHOD TO MEASURE CONCENTRATION OF DISINFECTANT IN MEDICAL DEVICE REPROCESSING SYSTEM ASP GLOBAL MANUFACTURING GMBH (CH) 2022-12-22 — — US claimed
EP-2509561-B1 A POROUS, DISSOLVABLE SOLID SUBSTRATE AND SURFACE RESIDENT COATING COMPRISING WATER SENSITIVE ACTIVES PROCTER & GAMBLE (US) 2017-08-02 — — EP claimed
US-20110195098-A1 Porous, Dissolvable Solid Substrate and Surface Resident Coating Comprising Water Sensitive Actives THE PROCTER & GAMBLE COMPANY 2011-08-11 — — US claimed
EP-0488980-B1 Use of acid-base indicators for improving the wet hiding power of emulsion paints FINA RESEARCH (BE) 2001-07-18 — — EP claimed
EP-0488980-A1 Process for improving the wet hiding power of emulsion paints FINA RESEARCH S.A. (BE) 1992-06-03 — — EP claimed
US-12551590-B2 Apparatus and method to measure concentration of disinfectant in medical device reprocessing system ASP GLOBAL MANUFACTURING GMBH (CH) 2026-02-17 — — US disclosed
EP-4257074-A3 APPARATUS AND METHOD TO MEASURE CONCENTRATION OF DISINFECTANT IN MEDICAL DEVICE REPROCESSING SYSTEM ASP Global Manufacturing GmbH (CH) 2024-01-03 — — EP disclosed
EP-4257074-A8 APPARATUS AND METHOD TO MEASURE CONCENTRATION OF DISINFECTANT IN MEDICAL DEVICE REPROCESSING SYSTEM ASP Global Manufacturing GmbH (CH) 2023-12-20 — — EP disclosed
EP-4257074-A2 REAGENT SOLUTION TO MEASURE CONCENTRATION OF DISINFECTANT ASP Global Manufacturing GmbH (CH) 2023-10-11 — — EP disclosed
EP-4257074-A2 REAGENT SOLUTION TO MEASURE CONCENTRATION OF DISINFECTANT ASP Global Manufacturing GmbH (CH) 2023-10-11 — — EP disclosed
EP-3789762-B1 REAGENT SOLUTION TO MEASURE CONCENTRATION OF DISINFECTANT ASP GLOBAL MFG GMBH (CH) 2023-08-30 — — EP disclosed
US-20110195098-A1 Porous, Dissolvable Solid Substrate and Surface Resident Coating Comprising Water Sensitive Actives THE PROCTER & GAMBLE COMPANY 2011-08-11 — — US disclosed
US-20110132387-A1 Porous, Dissolvable Solid Substrate And Surface Resident Coating Comprising A Skin Treatment Active THE GILLETTE COMPANY 2011-06-09 — — US disclosed
CN-1249509-C Ion-colour controlled electrophoresis display device LIU TIANMIN (CN) 2006-04-05 — — CN disclosed
CN-1461967-A Ion-colour controlled electrophoresis display device LIU TIANMIN (CN) 2003-12-17 — — CN disclosed
EP-0488980-B1 Use of acid-base indicators for improving the wet hiding power of emulsion paints FINA RESEARCH (BE) 2001-07-18 — — EP disclosed
EP-0543057-A1 Method for determining the oil content in oil-in-water emulsions QUAKER CHEMICAL CORPORATION (US) 1993-05-26 — — EP disclosed
EP-0488980-A1 Process for improving the wet hiding power of emulsion paints FINA RESEARCH S.A. (BE) 1992-06-03 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12551590-B2 Apparatus and method to measure concentration of disinfectant in medical device reprocessing system STS, SEC24C, HPD CYP2C9 611/4885SMN1; SMN2 2093/4885MEN1 960/4885
US-20110132387-A1 Porous, Dissolvable Solid Substrate And Surface Resident Coating Comprising A Skin Treatment Active CUTA, DSG1, CD44 CYP2C9 206/4885SMN1; SMN2 4406/4885MEN1 4647/4885
US-20110195098-A1 Porous, Dissolvable Solid Substrate and Surface Resident Coating Comprising Water Sensitive Actives CUTA, DSG1, SPG11 CYP2C9 1063/4885SMN1; SMN2 4384/4885MEN1 3586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback